Insider Transactions

DAY HI:
DAY LOW:
VOLUME:

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Insider Transactions

Date Name Title Type Shares Traded Price Range
Aug 31, 2022
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 25,000 --
Aug 31, 2022
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 75,000 --
Aug 31, 2022
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 27,380 --
Aug 31, 2022
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 86,301 --
Aug 31, 2022
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 25,000 --
Aug 31, 2022
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 75,000 --
Aug 31, 2022
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 25,000 --
Aug 31, 2022
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 75,000 --
Aug 31, 2022
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 25,000 --
Aug 31, 2022
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 75,000 --
Jun 23, 2022
Chief Medical Officer
Chief Medical Officer Open market or private sale of non-derivative or derivative security 6,667 $0.84
Jun 23, 2022
Chief Medical Officer
Chief Medical Officer Other acquisition or disposition -- --
Jun 23, 2022
Chief Legal Officer
Chief Legal Officer Other acquisition or disposition -- --
Jun 23, 2022
Director, CEO & President
Director, CEO & President Other acquisition or disposition -- --
Jun 22, 2022
Chief Medical Officer
Chief Medical Officer Open market or private sale of non-derivative or derivative security 6,096 $0.81
Jun 21, 2022
Director
Director Open market or private sale of non-derivative or derivative security 4,283 $0.79
Jun 21, 2022
EVP & CFO
EVP & CFO Grant, award or other acquisition pursuant to Rule 16b-3(d) 334,507 --
Jun 21, 2022
EVP & CFO
EVP & CFO Open market or private sale of non-derivative or derivative security 3,569 $0.79
Jun 21, 2022
EVP & CFO
EVP & CFO Grant, award or other acquisition pursuant to Rule 16b-3(d) 1,515,957 --
Jun 21, 2022
Director
Director Open market or private sale of non-derivative or derivative security 5,711 $0.79
Jun 21, 2022
Chief Medical Officer
Chief Medical Officer Grant, award or other acquisition pursuant to Rule 16b-3(d) 405,040 --
Jun 21, 2022
Chief Medical Officer
Chief Medical Officer Grant, award or other acquisition pursuant to Rule 16b-3(d) 1,488,940 --
Jun 21, 2022
Chief Legal Officer
Chief Legal Officer Grant, award or other acquisition pursuant to Rule 16b-3(d) 246,085 --
Jun 21, 2022
Chief Legal Officer
Chief Legal Officer Grant, award or other acquisition pursuant to Rule 16b-3(d) 904,077 --
Jun 21, 2022
Director, CEO & President
Director, CEO & President Grant, award or other acquisition pursuant to Rule 16b-3(d) 405,040 --

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.